These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12849145)

  • 1. Erythropoiesis and neuroprotection: two sides of the same coin?
    Grasso G
    Lancet Neurol; 2003 Jun; 2(6):332. PubMed ID: 12849145
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin and subarachnoid hemorrhage.
    Grasso G; Sfacteria A
    J Neurosurg; 2010 Mar; 112(3):699-700. PubMed ID: 20192676
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythropoietin depletes iron stores: antioxidant neuroprotection for ischemic stroke?
    Bailey DM; Robach P; Thomsen JJ; Lundby C
    Stroke; 2006 Oct; 37(10):2453. PubMed ID: 16917084
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluorescein angiography findings strengthen the theoretical basis for trialling neuroprotective agents in cerebral malaria.
    Maude RJ; Beare NA
    Trends Parasitol; 2009 Aug; 25(8):350-1. PubMed ID: 19635680
    [No Abstract]   [Full Text] [Related]  

  • 5. The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside.
    Ntaios G; Savopoulos C; Chatzinikolaou A; Hatzitolios AI
    Acta Neurol Scand; 2008 Dec; 118(6):362-6. PubMed ID: 18513348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia.
    van der Kooij MA; Groenendaal F; Kavelaars A; Heijnen CJ; van Bel F
    Brain Res Rev; 2008 Nov; 59(1):22-33. PubMed ID: 18514916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconsidering Neuroprotection in the Reperfusion Era.
    Savitz SI; Baron JC; Yenari MA; Sanossian N; Fisher M
    Stroke; 2017 Dec; 48(12):3413-3419. PubMed ID: 29146878
    [No Abstract]   [Full Text] [Related]  

  • 8. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.
    Erbayraktar S; Grasso G; Sfacteria A; Xie QW; Coleman T; Kreilgaard M; Torup L; Sager T; Erbayraktar Z; Gokmen N; Yilmaz O; Ghezzi P; Villa P; Fratelli M; Casagrande S; Leist M; Helboe L; Gerwein J; Christensen S; Geist MA; Pedersen LØ; Cerami-Hand C; Wuerth JP; Cerami A; Brines M
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6741-6. PubMed ID: 12746497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2007 Feinberg lecture: a new road map for neuroprotection.
    Donnan GA
    Stroke; 2008 Jan; 39(1):242. PubMed ID: 18048866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats.
    Belayev L; Khoutorova L; Zhao W; Vigdorchik A; Belayev A; Busto R; Magal E; Ginsberg MD
    Stroke; 2005 May; 36(5):1071-6. PubMed ID: 15790949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Perspective in current neuroprotection strategies.
    Okada H; Matsuda Y; Chung J; Webster Crowley R; Lopes DK
    Neurosurg Focus; 2017 Apr; 42(4):E5. PubMed ID: 28366072
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of erythropoietin.
    Gu YL; Zhao ZX
    J Neurosurg; 2014 Jan; 120(1):293-4. PubMed ID: 24180572
    [No Abstract]   [Full Text] [Related]  

  • 13. The many faces of erythropoietin: from erythropoiesis to a rational neuroprotective strategy.
    Grasso G; Sfacteria A
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1407-9. PubMed ID: 18808303
    [No Abstract]   [Full Text] [Related]  

  • 14. The many faces of erythropoietin: from erythropoiesis to a rational neuroprotective strategy--correspondence.
    Lapchak PA
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1615-6. PubMed ID: 18808321
    [No Abstract]   [Full Text] [Related]  

  • 15. [Erythropoietin and neuroprotection].
    Chatagner A; Hüppi PS; Ha-Vinh Leuchter R; Sizonenko S
    Arch Pediatr; 2010 Sep; 17 Suppl 3():S78-84. PubMed ID: 20728813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of progesterone treatment for ischaemic stroke.
    Gibson CL; Bath PM
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):487-91. PubMed ID: 26661235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Past, present and future of neuroprotection].
    Mracek J
    Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.
    Saver JL
    Pharmacotherapy; 2010 Jul; 30(7 Pt 2):62S-9S. PubMed ID: 20575624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What have we learned from clinical neuroprotective trials?
    Morgenstern LB
    Neurology; 2001; 57(5 Suppl 2):S45-7. PubMed ID: 11552054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Success of immunomodulators in MS shifts discovery focus to neuroprotection.
    Mullard A
    Nat Rev Drug Discov; 2011 Dec; 10(12):885-7. PubMed ID: 22129976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.